Your session is about to expire
What is Phyllocontin
Effectiveness
When to interrupt dosage
The measure of Phyllocontin is contingent upon the declared health issue, including Chronic Bronchitis, Lung Disorder and Bronchospasm. The amount of dosage is contingent upon the approach of delivery (e.g. Intravenous or Suppository) indicated in the table underneath.Warnings
There are 20 known major drug interactions with Phyllocontin.Phyllocontin Novel Uses: Which Conditions Have a Clinical Trial Featuring Phyllocontin?
158 active studies are currently assessing the potential of Phyllocontin to provide relief for conditions like Bronchitis, Chronic Bronchitis and Asthma.Phyllocontin Reviews: What are patients saying about Phyllocontin?
Patient Q&A Section about phyllocontin
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.Is there an alternative to Phyllocontin?
"If your doctor has prescribed Phyllocontin® for your asthma, they will contact you about your treatment options, which may include switching to Uniphyllin Continus, an alternative theophylline medication."
Is Phyllocontin an aminophylline?
"Phyllocontin is a medication used to treat and prevent bronchospasm, a condition in which the airways of the lungs narrow. It is used in adults for the treatment and prevention of bronchospasm associated with conditions such as asthma, chronic obstructive pulmonary disease, and chronic bronchitis. For children, it is used to manage asthma."
What is Phyllocontin used for?
"Aminophylline is an ingredient in these tablets that are used to treat asthma, long-term breathing difficulties, and sometimes heart failure in adults. These tablets belong to a group of medicines called bronchodilators."
When was Phyllocontin discontinued?
"The Department of Health and Social Care announced on February 12th that Phyllocontin® will be discontinued in the UK. The stock of 225mg tablets is expected to be exhausted by 30th March 2021 and the 350mg tablets is expected to be exhausted by 5th April 2021."